NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CFO Jay Matushak sold 4,970 shares of the stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10. Following the completion of the transaction, the chief financial officer now owns 17,747 shares in the company, valued at approximately $130,085.51. This trade represents a 21.88 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.
NeueHealth Trading Up 0.7 %
NEUE opened at $7.45 on Thursday. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $16.59. The firm has a market capitalization of $61.72 million, a PE ratio of -0.15 and a beta of 0.57. The firm’s 50-day moving average price is $5.51 and its 200 day moving average price is $5.39.
Analysts Set New Price Targets
Separately, Royal Bank of Canada dropped their price objective on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research note on Monday, December 9th.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in NEUE. Partners Group Holding AG purchased a new stake in NeueHealth in the 3rd quarter valued at about $463,000. Deer Management Co. LLC acquired a new stake in shares of NeueHealth during the second quarter valued at about $5,436,000. NEA Management Company LLC purchased a new stake in shares of NeueHealth in the 2nd quarter valued at approximately $14,834,000. Finally, Renaissance Technologies LLC acquired a new position in shares of NeueHealth in the 2nd quarter worth approximately $312,000. 63.88% of the stock is currently owned by institutional investors and hedge funds.
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
See Also
- Five stocks we like better than NeueHealth
- Stock Sentiment Analysis: How it Works
- Breaking the Mold: 3 Non-Tech Stocks Ready to Surge in 2025
- Energy and Oil Stocks Explained
- Your Best Trading Year Starts Here: Top 3 Stocks for 2025 Gains
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Warren Buffett Bets on the Digital Economy With New VeriSign Buy
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.